Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $6.00 --0%
Revenue Growth %: +17.5%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: +17.5%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.11), $0.12 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue
- First Bancorp to acquire First Carolina Bancshares for $166M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
